Page last updated: 2024-10-24

chlorambucil and Dysuria

chlorambucil has been researched along with Dysuria in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Dysuria: Painful URINATION. It is often associated with infections of the lower URINARY TRACT.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Palmisano, F1
Lorusso, V1
Spinelli, MG1
Dell'Orto, PG1
Montanari, E1

Reviews

1 review available for chlorambucil and Dysuria

ArticleYear
Blastoid variant of mantle cell lymphoma of the female urethra mimicking a caruncle: A rare but highly aggressive subtype case with literature review.
    Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2019, Mar-29, Volume: 91, Issue:1

    Topics: Aged, 80 and over; Antineoplastic Agents, Alkylating; Chlorambucil; Diagnosis, Differential; Disease

2019